Company profile


VZP0875 | Berlin

Canostix is developing a blood-based cancer test that combines photonics and machine learning, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines.

Business Model


Customer Focus


Top 10 out of more than 900 start-ups at the TATA Social Enterprise Challange 2019.

BAFA - INVEST - Zuschuss für Wagniskapital

Investmentbank Berlin - Gründungsbonus

Registered Office

Brandenburgische Straße 10
10713 Berlin


0049 152 58 666 662
Send mail

Management board

Leonard Diemer

Operations and Investor Relations

MUDr. Thaddäus Hocotz

Managing Director and Medical Expert

Dr. Kristina Kirchberg

Biochemical Analysis and Quality Management

Dr. Dipak Mitra

Network and Cooperation Manager

Lukasz Pieszczek

Data Analysis

Urszula Zabarylo

Head of R&D